0000899243-21-025045.txt : 20210621 0000899243-21-025045.hdr.sgml : 20210621 20210621173515 ACCESSION NUMBER: 0000899243-21-025045 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210618 FILED AS OF DATE: 20210621 DATE AS OF CHANGE: 20210621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Duncan Barbara Gayle CENTRAL INDEX KEY: 0001353128 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39661 FILM NUMBER: 211032149 MAIL ADDRESS: STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC. STREET 2: 18 DESBROSSES STREET CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Atea Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001593899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460574869 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 125 SUMMER STREET STREET 2: 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-204-8109 MAIL ADDRESS: STREET 1: 125 SUMMER STREET STREET 2: 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-18 0 0001593899 Atea Pharmaceuticals, Inc. AVIR 0001353128 Duncan Barbara Gayle 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110 1 0 0 0 Stock Option (Right to Buy) 23.39 2021-06-18 4 A 0 34025 0.00 A 2031-06-17 Common Stock 34025 34025 D The option vests and becomes exercisable in twelve (12) equal monthly installments following June 18, 2021, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. /s/ Andrea Corcoran, as Attorney-in-Fact for Barbara Gayle Duncan 2021-06-21